FIRM FIXED PRICE
TAKEDA PHARMACEUTICALS AMERICA INC - TAKHZYRO 150 MG
PIID: 36C24526N0104
Signed Date: Oct 16, 2025Effective Date: Oct 16, 2025End Date: Closed on Oct 17, 2025
Key Details
Description
TAKHZYRO 150 MG
Contractor Information
Contractor: TAKEDA PHARMACEUTICALS AMERICA INC
UEI: DDEVYUAXJ624
CAGE Code: 4DE70
Location: DEERFIELD, IL
Similar Awards
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER
MCKESSON CORPORATION
$1.4B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER
MCKESSON CORPORATION
$1.2B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 DECEMBER
MCKESSON CORPORATION
$1.1B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY
MCKESSON CORPORATION
$1.1B
LENALIDOMIDE FOR THE SALISBURY VAMC, CHARLOTTE HCC, AND KERNERSVILLE HCC.
EXELAN PHARMACEUTICALS INC
$5.1M
Stay Updated
Get notified about new opportunities matching your interests.